Tacrolimus monotherapy in OLT [orthotopic liver transplant] recipients with HCV [hepatitis C virus] under preemptive treatment with interferon and ribavirin

Status: Withdrawn prior to enrolment

Phase of Trial: Phase IV

Latest Information Update: 21 Nov 2013

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

Drugs Peginterferon alfa-2b (Primary) ; Ribavirin (Primary) ; Tacrolimus (Primary)
Indications Hepatitis C
Focus Therapeutic Use

17 Feb 2012 Planned End Date changed from 1 Jul 2009 to 1 Mar 2008 as reported by ClinicalTrials.gov.
03 Nov 2009 Actual end date (Mar 2008) added as reported by ClinicalTrials.gov record.
03 Nov 2009 Status changed from active, no longer recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com